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The thin end of
the rice grain?
 
y the second day of BIO 2001, San 
Diego’s conference center was buzz-
ing with activity. Inside the barricades 
were 14,000 registered participants and 
almost as many police officers; outside 
was a single raggedy group of seven 
protestors (two toddlers; five adults), one 
of whom looked like he had dropped 
way too much acid in the sixties.
This was the biotechnology industry’s 
showcase, and nothing was going to 
disrupt it—there was to be no repeat of 
the chaos in Seattle during the 1999 
meeting of the World Trade Organiza-
tion. After a mild protest on the first 
day, Kelli Gray, a food-science major at 
San Diego State University and member 
of the Greenpeace True Food Network, 
was one of the few dissenters left.
“It’s not really biotech that I have a 
problem with; it’s the government,” she 
said. Inadequate testing and labeling of 
genetically modified (GM) foods was her 
issue, and one that got support from a 
surprising quarter. Craig Venter of 
Celera Genomics (Rockville, MD), 
receiving a joint award with Francis Col-
lins (National Human Genome Re-
search Institute, Bethesda, MD) for co-
ordinating efforts to sequence the 
human genome, called GM food safety 
issues “answerable questions. The re-
search has not been funded to answer 
these questions.”
GM foods were the most vital thread 
B
 
in the sprawling meeting, 
and the new battleground 
appears to be the 
developing world. Stories 
from Africa and Asia were 
put forward as models for 
how biotechnology could 
benefit poorer countries. 
The alternative—that the 
agricultural biotechnology 
industry is using poorer 
countries as a way to force 
GM foods into reluctant 
markets—was vehemently 
denied, but in the end, the 
true story was difficult to as-
certain. In this debate, it comes down to 
determining motivations, and those mo-
tivations may well vary depending on 
which person from a particular project 
(from research scientist to company 
CEO) is doing the talking.
 
A glowing grain
 
Golden rice has become the poster child 
for agricultural biotechnology. The rice 
has three genes added to it so that it now 
makes 
 
 
 
-carotene (otherwise known as 
pro-vitamin A) and turns yellow. 
Vitamin A deficiency has been estimated 
to cause at least 500,000 cases of 
irreversible blindness per year, and 
between 1 and 2 million deaths per year, 
mostly in very young children. Golden 
rice has the potential to supply many of 
these people with pro-vitamin A in their 
food.
“We need more projects like golden 
rice,” said Shanthu Shantharam of seed 
giant Syngenta. “In this way society will 
understand some of the benefits of bio-
technology.” Shantharam introduced 
Peter Beyer (University of Freiburg, 
Germany), who with Ingo Potrykus 
(Swiss Federal Institute of Technology, 
Zurich, Switzerland) spearheaded the 
scientific effort to create golden rice.
The project started in academia with 
nonprofit funding, but when a new 
source of funding was needed, Beyer 
and Potrykus turned to the European 
Union, which requires that grantees 
have a commercial partner. This re-
quirement, and the need to get access to 
multiple agricultural biotechnology 
patents, resulted in a partnership with 
Zeneca, now part of Syngenta.
The Syngenta partnership and a 
Greenpeace campaign led to some 
negative publicity. In Potrykus’ opinion, 
the anti–golden rice campaign “has little 
to do with facts. It is a pseudo-religious 
Golden rice, here mixed with regular rice, is a source 
of pro-vitamin A.
 
Whole-genome shufﬂing
 
axygen, Inc. (Redwood City, CA) 
was founded on the technology 
of gene shuffling, in which test-tube 
experiments yield the sort of genetic 
reassortment normally seen as a result 
of sexual reproduction. In brief, 
multiple variants of a gene are 
subjected to cycles of cutting, 
reannealing, ligation, and testing for 
increased or novel activities based on 
the new combinations of genetic 
variants now found in the same 
molecule.
M
 
Now Russell Howard, CEO of 
Maxygen, has announced that the com-
pany has successfully extended the 
technique to whole genomes. Starting 
with related bacterial strains, Maxygen 
scientists shuffled the genomes in the 
test tube, then reconstituted organisms 
that now thrived in acidic conditions 
(pH 3.8) that the parent organisms 
could not tolerate. Howard said that 
the technique allows the company to 
optimize parameters even when the un-
derlying biology is not understood. 
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war—very emotional. A few groups that 
are antiglobalization, antitechnology, 
and antiscience see this as a very efficient 
battleground. They use the fear from 
incidents like BSE to spread the feeling 
that transgenic plants are something 
very dangerous. There are really no data 
to support that view.”
The first transfer of golden rice variet-
ies to a local research institute happened 
in January 2001, at the International 
Rice Research Institute (IRRI; Los 
Baños, Philippines). The recipient was 
Ronald Cantrell, IRRI’s director, who 
estimates that transferring the genes to 
local cultivars and boosting the levels of 
pro-vitamin A production will take 3 to 
5 years. As for the protests, “I don’t have 
a lot of time for people who don’t have 
something they can come up with that is 
a better alternative,” he said.
But Cantrell has more in mind for 
Ingo Potrykus (left) handing over golden-rice seeds to 
Ronald Cantrell (right) of IRRI in the Philippines.
 
golden rice than a fix for vitamin A 
deficiency—he hopes it will stimulate 
commerce. “Today there is no seed mar-
ket [in Asia], but it can be big,” he said. 
“I want that subsistence farmer, I want 
him to be able to purchase seed.”
Under the agreement with Syngenta, 
any farmer producing less than $10,000 
per year of grain has access to the tech-
nology for free. For those in the poorer 
countries, said Cantrell, “at some point 
they will start purchasing products, but 
it will not be golden rice.”
 
The African story
 
Florence Wambugu has been working in 
agricultural biotechnology for many 
years, but lately she has become the bio-
tech industry’s favorite spokesperson. She 
puts a forceful case that food-poor Africa 
is not interested in the West’s skittishness 
about GM foods, and 
that it resents outsiders 
telling it that it should 
not make use of this 
technology. Her views 
have been backed by the 
recent United Nations 
(UN) Human Develop-
ment Report 2001, 
which concludes that 
the possible benefits of 
GM food outweigh the 
risks for developing 
countries.
Wambugu, director 
of the ISAAA Afri-
Center in Nairobi, 
Kenya, agrees with 
Cantrell’s economic arguments. 
“Nobody gets out of poverty by beg-
ging,” she said. “The African commu-
nity has to get into the market economy. 
This technology is going to enable peo-
ple not only to become consumers but 
also . . . part of a global community.”
Agriculture sustains Africa, and yet 
production per hectare in Africa is less 
than half the average seen worldwide. 
Jocelyn Webster, executive director of the 
South African biotech organization 
AfricaBio, said that GM foods can work 
in Africa. “The benefits are packaged in a 
seed,” she said, “and that means the farm-
ers can have access to the technology.”
Unfortunately for Wambugu and 
Webster, opposition to GM foods exists 
both in Africa and its trading partners. A 
1999 AfricaBio survey found that 26% 
of South Africans were in favor of GM 
food, 19% were opposed, and 55% were 
unsure, and Webster said the opposed 
and unsure numbers have increased 
further following negative press in South 
Africa. Furthermore, Namibia recently 
stopped buying South African maize to 
feed its cows, because it was concerned 
that the 6% GM content in the feed 
would jeopardize their share of the Eu-
ropean beef market.
Despite these problems, there were 
over 70 applications for GM plant trials 
in South Africa last year alone, and 
Webster is not about to give up on 
GM technology. “Africa needs this 
technology,” she said. “There’s no doubt 
about it. There’s no debate about it. We 
need it.”
 
 
 
 
 
Forgetful ﬂies
 
im Tully (Cold Spring Harbor Laboratory, NY) has raised 
the stakes in fly memory research. It took ten calendar 
years, and approximately 50 person years, for Tully and oth-
ers to isolate the first three 
 
Drosophila
 
 genes implicated in 
memory and learning. But now in a large-scale screen, Tully 
and his colleagues have isolated 55 genes involved in fly 
learning and memory in just the last nine months.
Tully pairs certain odorants with electric shocks, then tests 
his mutants for their ability to learn to avoid the odorants. In 
normal flies, multiple, spaced training sessions are needed to 
cement an odorant–shock pair into long-term memory; multi-
ple training sessions without intervening gaps do not work. 
Tully has reported previously that he can override this system 
T
 
by expressing an activated form of the cAMP response ele-
ment binding protein (CREB), yielding flies that form a long-
term memory after a single training session.
Remembering is all very well, but will a CREB-stimulated 
brain overload? This is not just a question for the flies—Tully 
is involved with Helicon Therapeutics, Inc. (Uniondale, New 
York), which hopes to exploit CREB and other memory pro-
teins to treat brain degenerative disorders and perhaps to in-
crease memory abilities in normal individuals. But the answer 
may come first in flies. A fly brain can learn only five odor–
shock pairings before additional pairs displace the first set. 
Tully is now looking into whether CREB or the newly isolated 
genes affect this finite brain capacity. 
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